News

NEWS RELEASE: Providence Oregon and Aetna, a CVS Health company, have reached a multi-year agreement that brings Providence hospitals, clinics, and physicians across Oregon back in-network.

Providence Breast Care and Breast Surgery Clinics launch Prevention4ME, a groundbreaking program to empower women with personalized breast cancer risk assessments and proactive screening options.

Providence Cancer Institute researchers share important cancer research at SITC annual meeting and receive recognition for their contributions to science.

New studies at Providence Cancer Institute offer hope to patients with limited treatment options.

Providence Cancer Institute leader joined experts in cancer research, policy and advocacy to discuss current challenges and the future of research.

Providence medical breast oncologist to give a special presentation on Lobular Breast Cancer and the latest data on the development of a lobular prevention vaccine.

A medication designed to block and break down the androgen receptor, a key driver of prostate cancer growth, is being evaluated in a clinical trial at Providence Cancer Institute.

Get a behind the scenes peek into the work of a cancer research administrator as she reflects on her time at Providence Cancer Institute.

Two new trials evaluating new medications or combinations of medications for people with ovarian cancer or small cell lung cancer open at Providence Cancer Institute.